Who has been buying Invites Biocore stock?

2 distinct insiders have filed 63 disclosed insider purchases in Invites Biocore (216400), most recently on 2025-12-30. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Invites Biocore have?

Invites Biocore has 63 buy-side and 0 sell-side disclosures on record, covering ₩225M ($156K) in total reported value, spanning 2025-06-27 to 2025-12-30.

Where does StockDrifts get Invites Biocore insider data?

From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Invites Biocore 216400

Company

인바이츠바이오코아Invites Biocore

Insiders

Buys

Total Value

₩225M ($156K)

Avg Return

+15.32%

Last Filing

2025-12-30

Invites Biocore (216400) has 63 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩225M ($156K) in reported transaction value. The earliest filing StockDrifts holds for Invites Biocore is dated 2025-06-27; the most recent is 2025-12-30. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +15.32%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-07-24	BUY	Market Buy	신승수 Seungsu Shin	CEO	10.0K	₩394	+70.6%	₩2M ($2K)
2026-07-21	BUY	Market Buy	신승수 Seungsu Shin	CEO	20.0K	₩260	+51.5%	₩6M ($4K)
2026-07-16	BUY	Market Buy	신승수 Seungsu Shin	CEO	5.0K	₩296	+33.1%	₩2M ($1K)
2026-07-15	BUY	Market Buy	신승수 Seungsu Shin	CEO	10.0K	-	-	-
2025-12-30	BUY	Market Buy	인바이츠지노믹스 Invites Genomics	-	3.7K	₩4,555	-13.3%	₩17M ($12K)
2025-12-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	2.0K	₩2,000	+97.5%	₩4M ($3K)
2025-11-25	BUY	Market Buy	신승수 Seungsu Shin	CEO	2.0K	₩2,450	+61.2%	₩5M ($3K)
2025-11-21	BUY	Market Buy	인바이츠지노믹스 Invites Genomics	-	9.6K	₩2,495	+58.3%	₩24M ($17K)
2025-11-14	BUY	Market Buy	신승수 Seungsu Shin	CEO	1.0K	₩3,095	+27.6%	₩3M ($2K)
2025-11-10	BUY	Market Buy	신승수 Seungsu Shin	CEO	700	₩3,365	+17.4%	₩2M ($2K)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	94	₩3,600	+9.7%	₩338K ($235)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	96	₩3,600	+9.7%	₩346K ($240)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	17	₩3,600	+9.7%	₩61K ($43)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	1.3K	₩3,600	+9.7%	₩5M ($3K)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	49	₩3,600	+9.7%	₩176K ($123)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	63	₩3,600	+9.7%	₩227K ($158)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	323	₩3,600	+9.7%	₩1M ($808)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	29	₩3,600	+9.7%	₩104K ($73)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	50	₩3,600	+9.7%	₩180K ($125)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	48	₩3,600	+9.7%	₩173K ($120)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	57	₩3,600	+9.7%	₩205K ($143)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	45	₩3,600	+9.7%	₩162K ($113)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	84	₩3,600	+9.7%	₩302K ($210)
2025-11-04	BUY	Market Buy	신승수 Seungsu Shin	CEO	50	₩3,600	+9.7%	₩180K ($125)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	10	₩3,540	+11.6%	₩35K ($25)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	10	₩3,540	+11.6%	₩35K ($25)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	30	₩3,540	+11.6%	₩106K ($74)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	44	₩3,540	+11.6%	₩156K ($108)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	36	₩3,540	+11.6%	₩127K ($89)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	10	₩3,540	+11.6%	₩35K ($25)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	64	₩3,540	+11.6%	₩227K ($157)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	6	₩3,540	+11.6%	₩21K ($15)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	8	₩3,540	+11.6%	₩28K ($20)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	10	₩3,540	+11.6%	₩35K ($25)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	2.0K	₩3,540	+11.6%	₩7M ($5K)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	10	₩3,540	+11.6%	₩35K ($25)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	10	₩3,540	+11.6%	₩35K ($25)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	1	₩3,540	+11.6%	₩4K ($2)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	10	₩3,540	+11.6%	₩35K ($25)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	1	₩3,540	+11.6%	₩4K ($2)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	1	₩3,540	+11.6%	₩4K ($2)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	1	₩3,540	+11.6%	₩4K ($2)
2025-11-03	BUY	Market Buy	신승수 Seungsu Shin	CEO	38	₩3,540	+11.6%	₩135K ($93)
2025-10-23	BUY	Market Buy	신승수 Seungsu Shin	CEO	100	₩3,680	+7.3%	₩368K ($256)
2025-10-23	BUY	Market Buy	신승수 Seungsu Shin	CEO	2.0K	₩3,680	+7.3%	₩7M ($5K)
2025-10-23	BUY	Market Buy	신승수 Seungsu Shin	CEO	9	₩3,680	+7.3%	₩33K ($23)
2025-10-23	BUY	Market Buy	신승수 Seungsu Shin	CEO	1.1K	₩3,680	+7.3%	₩4M ($3K)
2025-10-23	BUY	Market Buy	신승수 Seungsu Shin	CEO	1.5K	₩3,680	+7.3%	₩5M ($4K)
2025-10-13	BUY	Market Buy	인바이츠지노믹스 Invites Genomics	-	1.5K	₩3,285	+20.2%	₩5M ($3K)
2025-09-30	BUY	Market Buy	인바이츠지노믹스 Invites Genomics	-	2.5K	₩3,115	+26.8%	₩8M ($5K)

Showing the 50 most recent of 67 filings.

Frequently asked questions

Who has been buying Invites Biocore stock?: 2 distinct insiders have filed 63 disclosed insider purchases in Invites Biocore (216400), most recently on 2025-12-30. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Invites Biocore have?: Invites Biocore has 63 buy-side and 0 sell-side disclosures on record, covering ₩225M ($156K) in total reported value, spanning 2025-06-27 to 2025-12-30.
Where does StockDrifts get Invites Biocore insider data?: From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Invites Biocore. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.